Clinical Trials
2 trialsNCT01392989 2019-05-07
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Stanford University
Phase 2 Completed
NCT00394888 2013-09-20
Hemangioma Associated With High Rates of Morbidity
Medical College of Wisconsin
Phase NA Completed